Journal of Pharmacology and Experimental Therapeutics: 274 (3)

September 01, 1995; Volume 274,Issue 3

Article

You have access
ERRATUM
Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1573;

You have access
Increases in non-N-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acidB transmission, in CA1 neurons during withdrawal from in vivo chronic ethanol treatment.
A Molleman and H J Little

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1035-1041;
You have access
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
H Kushida, S Nomura, O Morita, Y Harasawa, M Suzuki, M Nakano, K Ozawa and M Kunihara

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1042-1053;
You have access
The effects of chronic amphetamine treatment on prenatal ethanol-induced changes in dopamine receptor function: electrophysiological findings.
R Y Shen, J H Hannigan and L A Chiodo

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1054-1060;
You have access
Effect of tolbutamide on the rate of fatigue and recovery in frog sartorius muscle.
A Comtois, P Light and J M Renaud

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1061-1066;
You have access
Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
J R Cockcroft, P J Chowienczyk, S E Brett, C P Chen, A G Dupont, L Van Nueten, S J Wooding and J M Ritter

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1067-1071;
You have access
Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.
O N Chappey, E Niel, M Debray, J L Wautier and J M Scherrmann

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1072-1076;
You have access
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
J Jakubík, L Bacáková, E E el-Fakahany and S Tucek

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1077-1083;
You have access
Characterization of 125I-endothelin-1 binding to rat and rabbit renal microvasculature.
R M Edwards and W Trizna

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1084-1089;
You have access
Trifluoperazine modulates [3H]resiniferatoxin binding by human and rat vanilloid (capsaicin) receptors and affects 45Ca uptake by adult rat dorsal root ganglion neurones.
G Acs, M Palkovits and P M Blumberg

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1090-1098;
You have access
In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
H Nakamura, J Uetrecht, A E Cribb, M A Miller, N Zahid, J Hill, P D Josephy, D M Grant and S P Spielberg

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1099-1104;
You have access
Effects of the benzodiazepine inverse agonist RO19-4603 on the maintenance of tolerance to a single dose of ethanol.
H L June, S E Duemler, T L Greene, J A Williams, M Lin, S L Devaraju, S H Chen, M J Lewis and J M Murphy

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1105-1112;
You have access
Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
M D Swedberg, P Jacobsen and T Honoré

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1113-1121;
You have access
Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
A Mancinelli, A Longo, K Shanahan and A M Evans

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1122-1128;
You have access
Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
G M Ciuffo and J M Saavedra

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1129-1134;
You have access
Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
C Baylis, S Masilamani, G Losonczy, L Samsell, P Harton and K Engels

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1135-1141;
You have access
Quantitative and qualitative aspects of the hibernation-related reduction of morphine physical dependence in the ground squirrel (Citellus lateralis).
T A Beaver, F C Lewis, J R Newman and A L Beckman

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1142-1153;
You have access
Glucocorticoid receptor activation potentiates the morphine-induced adaptive increase in dopamine D-1 receptor efficacy in gamma-aminobutyric acid neurons of rat striatum/nucleus accumbens.
A N Schoffelmeer, T J De Vries, L J Vanderschuren, G H Tjon, P Nestby, G Wardeh and A H Mulder

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1154-1160;
You have access
Specificity of p-aminohippurate transport system in the OK kidney epithelial cell line.
J Nagai, M Takano, K Hirozane, M Yasuhara and K Inui

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1161-1166;
You have access
Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia.
B R Shivakumar, S V Kolluri and V Ravindranath

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1167-1173;
You have access
Blunting of renal excretory responses to acute volume expansion by nicotine: role of renal nerves.
K P Patel, P L Zhang and W G Mayhan

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1174-1181;
You have access
Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.
L H Parsons, G F Koob and F Weiss

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1182-1191;
You have access
Enantioselective effects of experimental diabetes mellitus on the metabolism of ibuprofen.
X Oian and S D Hall

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1192-1198;
You have access
Cerebrovascular permeability changes during experimental meningitis in the rat.
K M Boje

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1199-1203;
You have access
Stimulation by aminooxyacetate of fluorescein uptake in rat renal tubules in vitro: role of intracellular alpha-ketoglutarate.
A A Nikiforov

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1204-1208;
You have access
Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.
J Liu and B Moghaddam

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1209-1215;
You have access
Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
D Aharony, C K Buckner, J L Ellis, S V Ghanekar, A Graham, J S Kays, J Little, S Meeker, S C Miller and B J Undem

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1216-1221;
You have access
SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent.
D P Brooks, L C Contino, B G Short, C Gowan, W Trizna and R M Edwards

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1222-1227;
You have access
The pH dependence of cocaine interaction with cardiac sodium channels.
W J Crumb and C W Clarkson

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1228-1237;
You have access
ATP inhibits the synaptic release of acetylcholine in submucosal neurons.
C Barajas-López, M J Muller, B Prieto-Gómez and R Espinosa-Luna

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1238-1245;
You have access
Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
T Murohara, J P Guo and A M Lefer

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1246-1253;
You have access
SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
L A Marshall, R H Hall, J D Winkler, A Badger, B Bolognese, A Roshak, P L Flamberg, C M Sung, M Chabot-Fletcher and J L Adams

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1254-1262;
You have access
Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.
E E Codd, R P Shank, J J Schupsky and R B Raffa

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1263-1270;
You have access
Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
G Chen and D J Waxman

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1271-1277;
You have access
Intracellular alpha-ketoglutarate controls the efficacy of renal organic anion transport.
J B Pritchard

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1278-1284;
You have access
Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways.
M L Baker, L L Brockunier, J R Bagley, C P France and D J Carr

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1285-1292;
You have access
Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways.
N Watson, H Magnussen and K F Rabe

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1293-1297;
You have access
Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
A A Elfarra, R J Duescher, I Y Hwang, A R Sicuri and J A Nelson

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1298-1304;
You have access
The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids.
K R Powell and L A Dykstra

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1305-1316;
You have access
Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
D L Hammond, P E Stewart and L Littell

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1317-1324;
You have access
A primate model of polydrug abuse: cocaine and heroin combinations.
N K Mello, S S Negus, S E Lukas, J H Mendelson, J W Sholar and J Drieze

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1325-1337;
You have access
Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.
J D Winkler, A N Fonteh, C M Sung, J D Heravi, A B Nixon, M Chabot-Fletcher, D Griswold, L A Marshall and F H Chilton

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1338-1347;
You have access
Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
S Nowicki, J A Opezzo, G Levin, D Gonzalez and M M Elias

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1348-1354;
You have access
Relative potencies of volatile anesthetics in altering the kinetics of ion channels in BC3H1 cells.
R E Wachtel

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1355-1361;
You have access
Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
O Takenaka, T Horie, H Suzuki and Y Sugiyama

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1362-1369;
You have access
JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.
K Toide, Y Iwamoto, T Fujiwara and H Abe

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1370-1378;
You have access
Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion.
G P Thomas, S E Howlett and G R Ferrier

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1379-1386;
You have access
Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
G J Keil and G E Delander

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1387-1392;
You have access
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
D C Bolser, D J Blythin, R W Chapman, R W Egan, J A Hey, C Rizzo, S C Kuo and W Kreutner

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1393-1398;
You have access
Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
D A Hosford, Y Wang, C C Liu and O C Snead

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1399-1403;
You have access
The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
M R Szewczak, R Corbett, D K Rush, C A Wilmot, P G Conway, J T Strupczewski and M Cornfeldt

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1404-1413;
You have access
Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
P M Callahan and K A Cunningham

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1414-1424;
You have access
Pharmacological characterization of purinoceptor-mediated constriction of submucosal arterioles in guinea pig ileum.
J J Galligan, A Herring and T Harpstead

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1425-1430;
You have access
Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.
D Wu, S V Otton, W Kalow and E M Sellers

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1431-1437;
You have access
Cyclosporin A affects red blood cell deformability in vivo but not in vitro in guinea pig.
O K Başkurt, U K Sentürk, N Dayan, V Küçükatay, M Isbir, A Erkiliç and I Kaputlu

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1438-1442;
You have access
Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice.
P C Contreras, C Steffler, E Yu, K Callison, D Stong and J L Vaught

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1443-1449;
You have access
Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroids.
P A Klekotka, T H Richardson, E F Johnson and J R Halpert

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1450-1455;
You have access
Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.
J A Schetz, C A Mayr, J E Taylor, M Rosenblatt, M Chorev and T P Davis

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1456-1462;
You have access
The pharmacological modulation of angiogenesis in chronic granulomatous inflammation.
P R Colville-Nash, C A Alam, I Appleton, J R Brown, M P Seed and D A Willoughby

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1463-1472;
You have access
Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.
K Y Little, F I Carroll and B J Cassin

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1473-1483;
You have access
Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists.
R L Klein, M P Mascia, P C Harkness, K L Hadingham, P J Whiting and R A Harris

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1484-1492;
You have access
Calcium channel activation mobilizes calcium from a restricted pericellular region surrounding canine coronary artery smooth muscle cells.
E S Wheeler-Clark and L M Buja

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1493-1506;
You have access
Mechanisms underlying endothelium-independent relaxation by acetylcholine in canine retinal and cerebral arteries.
N Toda, J X Zhang, K Ayajiki and T Okamura

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1507-1512;
You have access
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells.
M M Belcheva, S Gucker, D M Chuang, W G Clark, L B Jefcoat, R J McHale, G Toth, A Borsodi and C J Coscia

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1513-1523;
You have access
Role of transforming growth factor-beta 1 on platelet-induced enhancement of endothelin-1 production in cultured vascular endothelial cells.
S Murata, Y Matsumura, K Takada, Y Asai, M Takaoka and S Morimoto

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1524-1530;
You have access
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
C C Chan, S Boyce, C Brideau, A W Ford-Hutchinson, R Gordon, D Guay, R G Hill, C S Li, J Mancini and M Penneton

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1531-1537;
You have access
Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats.
A Díaz, F Ruíz, J Flórez, A Pazos and M A Hurlé

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1538-1544;
You have access
Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
A Diaz, F Ruiz, J Flórez, M A Hurlé and A Pazos

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1545-1551;
You have access
Selective modulation of elements of the immune system by low molecular weight nucleosides.
M G Goodman, A B Reitz, R Chen, M D Bobardt, J H Goodman and B L Pope

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1552-1557;
You have access
[3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
S L Gackenheimer, J M Schaus and D R Gehlert

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1558-1565;
You have access
Characterization of a delta opioid receptor in rat pheochromocytoma cells.
M E Abood and Q Tao

Journal of Pharmacology and Experimental Therapeutics September 1995, 274 (3) 1566-1573;

Main menu

User menu

Search

Table of Contents

Article

In this issue

Jump to

Navigate

More Information

ASPET's Other Journals